President Trump has directed a federal change affecting state-licensed medical cannabis programs, shaking up how the plant is treated under federal law while stopping short of nationwide legalization. The move alters the drug’s classification and shifts enforcement priorities, but legal limits and bureaucratic processes mean patients, businesses, and courts will …